{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:47:30Z","timestamp":1787240850773,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2060"],"award-info":[{"award-number":["FOR2060"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.redox.2021.102179","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T02:59:28Z","timestamp":1636167568000},"page":"102179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia"],"prefix":"10.1016","volume":"48","author":[{"given":"Nadja I.","family":"Bork","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Cruz Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina E.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Friebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4392-185X","authenticated-orcid":false,"given":"Boris V.","family":"Skryabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timofey S.","family":"Rozhdestvensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lukowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-5179","authenticated-orcid":false,"given":"Viacheslav O.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2021.102179_bib1","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0235-1","article-title":"Hypoxia signaling in human diseases and therapeutic targets","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib3","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00534.2002","article-title":"Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study","volume":"285","author":"Pei","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib4","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.redox.2021.102179_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.114.302437","article-title":"Transgenic mice for real time visualization of cGMP in intact adult cardiomyocytes","volume":"114","author":"G\u00f6tz","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000000773","article-title":"Myocardial phosphodiesterases and their role in cGMP regulation","volume":"75","author":"Dunkerly-Eyring","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"10","key":"10.1016\/j.redox.2021.102179_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101672","article-title":"Modulation of compartmentalised cyclic nucleotide signalling via local inhibition of phosphodiesterase activity","volume":"17","author":"Brescia","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2011.02.019","article-title":"Phosphodiesterases and cardiac cGMP: evolving roles and controversies","volume":"32","author":"Zhang","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.redox.2021.102179_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000258451.44949.d7","article-title":"Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart","volume":"100","author":"Yan","year":"2007","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.redox.2021.102179_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"20","key":"10.1016\/j.redox.2021.102179_bib11","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.redox.2021.102179_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1159","article-title":"The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions","volume":"20","author":"Ambrosy","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"24","key":"10.1016\/j.redox.2021.102179_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.117.028723","article-title":"cGMP-elevating compounds and ischemic conditioning provide cardioprotection against ischemia and reperfusion injury via cardiomyocyte-specific BK channels","volume":"136","author":"Frankenreiter","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvy039","article-title":"Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase","volume":"114","author":"Frankenreiter","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.redox.2021.102179_bib16","article-title":"cGMP and mitochondrial K(+) channels-Compartmentalized but closely connected in cardioprotection","author":"Lukowski","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006036","article-title":"Simultaneous live cell imaging using dual FRET sensors with a single excitation Light","volume":"4","author":"Niino","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.redox.2021.102179_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.004940","article-title":"Enhanced expression of beta3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase","volume":"129","author":"Belge","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2021.102179_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52221","article-title":"beta3-Adrenoceptor redistribution impairs NO\/cGMP\/PDE2 signalling in failing cardiomyocytes","volume":"9","author":"Schobesberger","year":"2020","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.redox.2021.102179_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000172","article-title":"Persistent cAMP-signals triggered by internalized G-protein-coupled receptors","volume":"7","author":"Calebiro","year":"2009","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.redox.2021.102179_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax2941","article-title":"Pervasive head-to-tail insertions of DNA templates mask desired CRISPR-Cas9-mediated genome editing events","volume":"6","author":"Skryabin","year":"2020","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.redox.2021.102179_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2010.198","article-title":"FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells","volume":"6","author":"B\u00f6rner","year":"2011","journal-title":"Nat. Protoc."},{"issue":"24","key":"10.1016\/j.redox.2021.102179_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2012.01.060","article-title":"Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias","volume":"59","author":"Molina","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.redox.2021.102179_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083910","article-title":"Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI\/PET imaging","volume":"8","author":"Methner","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.redox.2021.102179_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005077","article-title":"Real-time imaging of HIF-1alpha stabilization and degradation","volume":"4","author":"Moroz","year":"2009","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.redox.2021.102179_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14835","article-title":"Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts","volume":"176","author":"Menges","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.redox.2021.102179_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000165128.39715.87","article-title":"Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure","volume":"111","author":"Ding","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.redox.2021.102179_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.107.167817","article-title":"Spatiotemporal dynamics of \u03b2-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes","volume":"102","author":"Leroy","year":"2008","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.redox.2021.102179_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/S0008-6363(00)00136-X","article-title":"Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia","volume":"47","author":"El Banani","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"26","key":"10.1016\/j.redox.2021.102179_bib30","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.236869","article-title":"An ion-insensitive cAMP biosensor for long term quantitative ratiometric fluorescence resonance energy transfer (FRET) measurements under variable physiological conditions","volume":"286","author":"Salonikidis","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.redox.2021.102179_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s00216-015-8636-z","article-title":"pH sensitivity of FRET reporters based on cyan and yellow fluorescent proteins","volume":"407","author":"Betolngar","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"12","key":"10.1016\/j.redox.2021.102179_bib32","article-title":"Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection","volume":"1782","author":"Nedelsky","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.redox.2021.102179_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2021.102179_bib34","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-physiol-021909-135757","article-title":"Autophagy during cardiac stress: joys and frustrations of autophagy","volume":"72","author":"Gottlieb","year":"2010","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib35","doi-asserted-by":"crossref","DOI":"10.4161\/auto.27367","article-title":"The vacuole versus the lysosome: when size matters","volume":"10","author":"Klionsky","year":"2014","journal-title":"Autophagy"},{"issue":"41","key":"10.1016\/j.redox.2021.102179_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0506489102","article-title":"A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis","volume":"102","author":"Ding","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.redox.2021.102179_bib37","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.redox.2021.102179_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.redox.2021.102179_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2013.08.003","article-title":"Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury","volume":"64","author":"Oikawa","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.87.2.118","article-title":"Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation","volume":"87","author":"Kang","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2021.102179_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-17-50","article-title":"Calcium-sensing receptors regulate cardiomyocyte Ca2+ signaling via the sarcoplasmic reticulum-mitochondrion interface during hypoxia\/reoxygenation","volume":"17","author":"Lu","year":"2010","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvt257","article-title":"NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size","volume":"101","author":"Bice","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-013-0337-1","article-title":"Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G","volume":"108","author":"Methner","year":"2013","journal-title":"Basic Res. Cardiol."},{"issue":"2\u20133","key":"10.1016\/j.redox.2021.102179_bib44","article-title":"Cyclic GMP in the perfused rat heart Effect of ischaemia, anoxia and nitric oxide synthase inhibitor","volume":"345","author":"Depr\u00e9","year":"1994","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/BF02124074","article-title":"Cyclic nucleotide levels in the perfused rat heart subjected to hypoxia","volume":"33","author":"Nesher","year":"1977","journal-title":"Experientia"},{"issue":"5 Pt 2","key":"10.1016\/j.redox.2021.102179_bib46","article-title":"L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism","volume":"276","author":"Agullo","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib47","doi-asserted-by":"crossref","DOI":"10.1023\/B:CARD.0000029027.50796.84","article-title":"Nitric Oxide synthase (NOS) does not contribute to simulated ischaemic preconditioning in an isolated rat cardiomyocyte model","volume":"18","author":"Strijdom","year":"2004","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"9","key":"10.1016\/j.redox.2021.102179_bib48","doi-asserted-by":"crossref","DOI":"10.1006\/jmcc.1996.0178","article-title":"Effect of anoxia on cyclic nucleotides and inositol phosphate turnover in cardiac myocytes","volume":"28","author":"Geisbuhler","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"17","key":"10.1016\/j.redox.2021.102179_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1416230112","article-title":"Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia\/reperfusion injury","volume":"112","author":"Chung","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/hc3201.092216","article-title":"Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase","volume":"104","author":"Sanada","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.redox.2021.102179_bib51","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.108.136218","article-title":"6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts","volume":"326","author":"Fukasawa","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(00)00759-2","article-title":"Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group","volume":"36","author":"Lowes","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.redox.2021.102179_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1074248412475158","article-title":"A model of hypoxia-reoxygenation on isolated adult mouse cardiomyocytes: characterization, comparison with ischemia-reperfusion, and application to the cardioprotective effect of regular treadmill exercise","volume":"18","author":"Portal","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"issue":"45","key":"10.1016\/j.redox.2021.102179_bib54","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M703173200","article-title":"Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes","volume":"282","author":"Vandeput","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib55","article-title":"ERES: sites for autophagosome biogenesis and maturation?","volume":"128","author":"Sanchez-Wandelmer","year":"2015","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib56","article-title":"Membrane dynamics in autophagosome biogenesis","volume":"128","author":"Carlsson","year":"2015","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.redox.2021.102179_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.111.300003","article-title":"Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart","volume":"112","author":"Beca","year":"2013","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.redox.2021.102179_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14912","article-title":"Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischaemia\/reperfusion injury by inhibiting glycogen synthase kinase-3beta-mediated activation of autophagy","volume":"177","author":"Gao","year":"2020","journal-title":"Br. J. Pharmacol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721003396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721003396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:21:06Z","timestamp":1761978066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721003396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":58,"alternative-id":["S2213231721003396"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.102179","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.102179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102179"}}